did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9780824729424

Neurogenetics: Scientific and Clinical Advances

by ;
  • ISBN13:

    9780824729424

  • ISBN10:

    0824729420

  • Edition: 1st
  • Format: Hardcover
  • Copyright: 2005-11-01
  • Publisher: CRC Press

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $230.00 Save up to $85.10
  • Rent Book $144.90
    Add to Cart Free Shipping Icon Free Shipping

    TERM
    PRICE
    DUE
    USUALLY SHIPS IN 3-5 BUSINESS DAYS
    *This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.

Supplemental Materials

What is included with this book?

Summary

Children's Hospital, Philadelphia, PA. Text presents current perspectives on neurogenetic disease both from clinical and scientific perspectives. Topics include genetic testing, ethical dilemmas, gene therapy, genetic counseling, and more. For researchers and clinicians.

Table of Contents

Foreword iii
Preface v
Contributors xvii
Neurogenetics in the Clinic
1(10)
Thomas D. Bird
Factors Suggesting a Neurogenetic Disorder
1(1)
Neurogenetic Diseases ``Hiding'' in Nonspecific Categories
2(1)
Importance of Family History
3(2)
Assessment of Sporadic Cases
5(1)
Genetic Counseling
6(2)
Genetic Testing
8(1)
Neurogenetics Information Resources
8(1)
An Integrated Clinical Neurogenetics Strategy
9(1)
References
10(1)
Genetic Testing for Neurological Disorders
11(16)
Martha A. Nance
Introduction
11(1)
Principles of Genetic Inheritance
11(3)
Genotype Changes and Their Significance in Phenotypic Appearance
14(1)
Gene Mutations and Assays to Detect Them
15(2)
Clinical Use of Gene Tests
17(6)
Resources for the Clinician
23(1)
References
23(4)
Genetic Counseling
27(16)
Robin L. Bennett
Introduction
27(1)
Are Genetic Disorders Unique?
27(3)
Who Are Genetic Counselors?
30(1)
The Process of Genetic Counseling
31(1)
Genetic Family History---The Pedigree
31(4)
Pedigree Analysis and Risk Perception
35(5)
Summary
40(1)
References
40(3)
Gene Therapy for Inherited Diseases of the Central Nervous System
43(44)
Tyler Mark Pierson
John H. Wolfe
Introduction
43(1)
General Properties of CNS Gene Therapy
44(1)
Candidate Diseases for Gene Therapy in the CNS
45(5)
Animal Models of Genetic CNS Disorders
50(4)
Lysosomal Storage Disease: Animal Models as a Paradigm for CNS Gene Therapy
54(2)
Gene Delivery Vehicles
56(11)
Summary
67(1)
References
68(19)
Ethical Dilemmas in Neurogenetics
87(20)
Wendy R. Uhlmann
Testing Minors
89(1)
Testing a Child for Adoption
89(2)
Testing an Adult Child When the At-Risk Parent Refuses Testing
91(1)
Is There a ``Duty to Warn'' and Share Test Results with Other At-Risk Family Members?
92(1)
Testing Identical Twins
93(1)
Non-Disclosure of Test Results
94(1)
Testing Siblings Simultaneously
95(1)
Testing Individuals Who Work in Professions Where Neurological Deficits Can Jeopardize the Safety of Others
96(1)
Testing Symptomatic Individuals Who Think They Are Asymptomatic
96(1)
Testing ``Asymptomatic'' Individuals Who have Recently Attempted Suicide
97(1)
Testing a Blood Sample from Someone Who Has Just Committed Suicide
98(1)
Testing a Pregnancy
98(2)
Giving Informed Consent for Individuals with Cognitive/Psychiatric Impairment
100(1)
Insurance Issues
101(1)
Anonymous Testing
101(1)
Legal Cases
102(1)
Resources
102(1)
Summary
102(1)
Recommended Reading
103(1)
References
103(4)
Autosomal Dominant Charcot-Marie-Tooth Disease and Related Disorders
107(22)
Craig L. Bennett
Scope of This Chapter
107(1)
CMT: Background and General Clinical Features
107(1)
Electrophysiological Classification of CMT
108(1)
Major Forms of Demyelinating CMT1
109(8)
Major Forms of Demyelinating CMT2
117(5)
Prognosis in CMT
122(1)
Summary
122(1)
Electronic Databases
122(1)
References
122(7)
Duchenne and Becker Muscular Dystrophies
129(28)
Leta S. Steffen
Louis M. Kunkel
Introduction
129(2)
Clinical Symptoms
131(1)
Clinical Diagnosis
132(2)
Clinical Treatment
134(2)
History of the Dystrophin Discovery
136(1)
Dystrophin---Molecular Characterization
137(1)
Animal Models of DMD
138(1)
Current Research for DMD/BMD Therapies
139(6)
Conclusion
145(1)
References
145(12)
The Congenital and Limb-Girdle Muscular Dystrophies
157(22)
Janbernd Kirschner
Carsten G. Bonnemann
Introduction
157(1)
Congenital Muscular Dystrophies
158(12)
Limb-Girdle Muscular Dystrophies
170(3)
References
173(6)
Non-dystrophic Myotonias and Periodic Paralyses
179(18)
Arie Struyk
Stephen Cannon
Introduction
179(3)
Chloride Channel Myotonias (Myotonia Congenita)
182(2)
Sodium Channel Myotonia and Periodic Paralysis
184(4)
Hypokalemic Periodic Paralysis
188(3)
Andersen's Syndrome
191(2)
Conclusions
193(1)
References
193(4)
The Myotonic Dystrophies---Effects of an RNA Mutation
197(16)
John W. Day
Laura P. W. Ranum
Introduction
197(1)
Clinical Features of the Myotonic Dystrophies
198(3)
Genetics of the Myotonic Dystrophies
201(3)
Molecular Pathogenesis of the Myotonic Dystrophies
204(3)
Reports of a Third Form of Myotonic Dystrophy
207(1)
Summary
207(1)
References
208(5)
Spinal Muscular Atrophy
213(18)
Stephen J. Kolb
J. Paul Taylor
Introduction
213(1)
Clinical Features of Autosomal Recessive SMA
214(1)
Molecular Genetics of Autosomal Recessive SMA
215(1)
SMA Unrelated to Mutations in SMN1
216(1)
Basic Research on Autosomal Recessive SMA: The SMN Complex
217(3)
Model Systems
220(1)
Therapeutics
220(3)
References
223(8)
Hereditary Spastic Paraplegia
231(30)
Kleopas A. Kleopa
Introduction
231(1)
Clinical and Pathological Features of HSP
231(4)
Genetics and Neurobiology of HSP
235(12)
Diagnostic Approach and Treatment in HSP
247(1)
Conclusion
248(1)
References
249(12)
Mitochondrial Disorders
261(28)
Clotilde Lagier-Tourenne
Michio Hirano
Introduction
261(1)
Principles of Mitochondrial Genetics
262(2)
Primary Mitochondrial DNA Mutations
264(1)
Nuclear DNA Mutations
265(4)
General Features of Mitochondrial Diseases
269(6)
Specific Mitochondrial Diseases
275(3)
MELAS
278(4)
References
282(7)
Friedreich Ataxia
289(22)
Martin B. Delatycki
Michael C. Fahey
Louise Corben
Andrew Churchyard
Introduction
289(1)
Clinical Features
289(3)
Pathology
292(1)
Molecular Genetics
292(2)
Pathogenesis
294(2)
Management of Patients with FRDA
296(4)
Potential Pharmacological Therapies for FRDA
300(2)
Conclusion
302(1)
References
302(9)
Autosomal Dominant Ataxias
311(46)
Susan L. Perlman
Introduction
311(2)
The Typical Dominant Ataxias
313(1)
SCA1
314(12)
SCA2
326(2)
SCA3
328(1)
SCA4
329(1)
SCA5
330(1)
SCA6
330(2)
SCA7
332(1)
SCA8
333(2)
SCA9
335(1)
SCA10
335(1)
SCA11
336(1)
SCA12
336(1)
SCA13
337(1)
SCA14
337(1)
SCA15
338(1)
SCA16
339(1)
SCA17
339(2)
SCA18
341(1)
SCA19
341(1)
SCA20
342(1)
SCA21
343(1)
SCA22
343(1)
SCA23
344(1)
SCA24
344(1)
SCA25
344(1)
SCA26
345(1)
SCA Due to FGF14
345(1)
Conclusion
346(1)
References
346(11)
Huntington's Disease: Mechanisms of Pathogenesis and Development of New Therapies
357(26)
Blair R. Leavitt
Lynn A. Raymond
Clinical, Pathologic, and Genetic Features of Huntington's Disease
357(4)
Animal Models of HD
361(3)
Pathogenesis of HD
364(5)
Preclinical Trials in Mouse Models of HD
369(1)
Clinical Trials in HD
370(3)
Conclusions
373(1)
References
373(10)
Wilson's Disease
383(20)
George J. Brewer
Introduction and Historical Overview
383(1)
Pathophysiology
384(1)
Genetics and Epidemiology
384(2)
Clinical Presentations
386(3)
Recognition, Screening, and Diagnosis
389(3)
Treatment with Anticopper Drugs
392(4)
Prognosis
396(1)
References
397(6)
Neurogenetics of Dystonia and Paroxysmal Dyskinesias
403(24)
Jennifer Friedman
David G. Standaert
Dystonia
403(4)
Genetics of Primary Dystonias
407(3)
Genetics of Dystonia Plus Syndromes
410(5)
Genetics of Paroxysmal Dystonias and Dyskinesias
415(2)
References
417(10)
Inherited Epilepsies
427(42)
Yr Sigurdardottir
Annapurna Poduri
Introduction
427(1)
Channelopathies
428(12)
Myoclonic Epilepsies
440(8)
Generalized Epilepsy Syndromes
448(2)
Localization-Related Epilepsy Syndromes
450(2)
Conclusion
452(1)
References
452(17)
Leukodystrophies
469(86)
James Y. Garbern
Introduction
469(1)
Disorders of Myelin Lipid Metabolism
470(48)
Closing Thoughts
518(1)
Resources
518(1)
References
519(36)
Lysosomal Storage Disorders
555(28)
David A. Wenger
Stephanie Coppola
Introduction
555(1)
General Concepts
556(2)
Clinical Features that Suggest a LSD
558(6)
Diagnosis of LSDs
564(8)
Treatment of LSDs
572(5)
References
577(6)
The Tuberous Sclerosis Complex: Clinical Manifestations and Molecular Genetics
583(16)
John R. Pollard
Peter B. Crino
Clinical Features of TSC
583(2)
Neurological Manifestations
585(1)
Neuropathology
586(1)
Genetics
587(2)
Signaling Pathway and Cell Biology
589(3)
Conclusion
592(1)
References
593(6)
Neurofibromatosis
599(22)
Amit Malhotra
James Dowling
David H. Gutmann
Introduction
599(1)
Neurofibromatosis 1
600(9)
Clinical Features of Neurofibromatosis 2
609(3)
References
612(9)
Genetics of Parkinson's Disease
621(22)
Sathya R. Sriram
Valina L. Dawson
Ted M. Dawson
Introduction
621(1)
Genes Linked to Familial PD
622(11)
Clinical Testing for Genetic Forms of PD
633(1)
Conclusion
634(1)
References
634(9)
Alzheimer's Disease
643(20)
R. Scott Turner
Introduction
643(1)
Epidemiology
643(1)
Clinical Criteria
644(1)
Pathologic Criteria
644(2)
Risk Factors
646(1)
Genetics of Familial AD
647(4)
Genetics of Sporadic (Late-Onset) Alzheimer's Disease
651(1)
The Amyloid Hypothesis
652(1)
Genetic Testing
653(1)
Current Treatment Strategies
654(1)
Future Treatment Strategies
655(2)
Perspectives
657(1)
References
658(5)
Tauopathies
663(30)
John C. van Swieten
Introduction
663(1)
Tau Gene---Tau Protein
663(2)
Frontotemporal Dementia
665(1)
FTDP-17
666(5)
Pathology of FTDP-17
671(9)
Conclusions
680(1)
References
681(12)
Amyotrophic Lateral Sclerosis
693(36)
Teepu Siddique
Lisa Dellefave
ALS Background
693(10)
Approaches to Mendelian Inherited ALS
703(3)
Understanding ALS Pathophysiology Through Mendelian Inherited ALS
706(8)
Approaches to SALS as a Genetically Complex or Multifactorial Disorder
714(3)
Clinical Management
717(1)
Remaining Questions to Be Answered
718(1)
References
719(10)
Prion Diseases
729(20)
William S. Baek
James A. Mastrianni
Introduction
729(1)
Historical Background
729(1)
Prion Protein (PrP) and the Prion Concept
730(1)
Pathogenesis of Prions
731(1)
Transmissible Properties of Prions
732(1)
Epidemiology
733(1)
Mutations of PRNP Cause Familial PrD
733(2)
PRNP Polymorphisms
735(1)
Prion-Like Protein Gene (Prnd)
736(1)
The Phenotypes of PrD
737(3)
Diagnosis of Prion Disease
740(1)
Diagnostic Studies
741(1)
Treatment
741(1)
References
741(8)
Index 749(8)
About the Editor 757

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program